3,050 HCA Healthcare, Inc. $HCA Shares Acquired by Pzena Investment Management LLC

Pzena Investment Management LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 99,648 shares of the company’s stock after acquiring an additional 3,050 shares during the quarter. Pzena Investment Management LLC’s holdings in HCA Healthcare were worth $42,524,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of HCA. MidFirst Bank purchased a new stake in HCA Healthcare during the second quarter valued at about $28,000. Clearstead Trust LLC acquired a new stake in HCA Healthcare during the second quarter worth about $29,000. Latitude Advisors LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter worth about $32,000. Cedar Mountain Advisors LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at about $33,000. Finally, Delos Wealth Advisors LLC purchased a new position in HCA Healthcare in the second quarter valued at approximately $35,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Hospitals and health insurers rallied after Democrats’ midterm gains, a sector-wide move that likely helped lift HCA. The coverage does not specify which policy changes investors expect. Article: Health insurers, hospitals rally after sweeping midterm win for Democrats
• Positive Sentiment: HCA’s quarterly results beat expectations: adjusted earnings were $7.22 per share versus a $6.65 consensus estimate, and revenue was $19.85 billion versus $19.33 billion. Revenue grew 3.6% year over year. Article: Why HCA Healthcare is a top growth stock for the long term
• Positive Sentiment: Wells Fargo raised its price target on HCA, while Truist reaffirmed its Buy rating and lifted its target to $510 from $495. These moves signal continued analyst support. Article: HCA Healthcare stock gets price target boost from Wells Fargo Article: Truist reaffirms Buy rating
• Positive Sentiment: HCA Houston Healthcare Northwest introduced next-generation robotic-assisted surgical technology, which may strengthen its service offering and competitive position. Article: HCA Houston Healthcare Northwest introduces robotic-assisted surgical technology
• Neutral Sentiment: HCA is planning a $300 million hospital in Cape Coral, with $31 million in city incentives. The project supports expansion, though its investment and execution costs may take time to translate into returns. Article: Cape Coral lands $300 million HCA hospital
• Neutral Sentiment: HCA launched a senior-notes offering; the article listing does not provide details on terms or intended use of proceeds, so the effect on leverage is unclear. Article: HCA Healthcare launches senior notes offering
• Negative Sentiment: Uninsured-patient costs reportedly shifted by $400 million in HCA’s third-quarter payer mix, a potential headwind to profitability. Article: HCA Q3 revenue by payer as uninsured shift costs $400M
• Negative Sentiment: Reports of data breaches involving HCA raise potential privacy, regulatory, and reputational concerns; the article listing does not specify the impact. Article: Data breaches announced by HCA Healthcare
• Negative Sentiment: A law firm announced an investigation into claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but it can create legal and reputational uncertainty. Article: Pomerantz investigates claims on behalf of HCA investors

HCA Healthcare Stock Up 10.3%

Shares of HCA Healthcare stock opened at $510.31 on Thursday. The business has a 50-day moving average price of $440.51 and a 200 day moving average price of $444.90. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm has a market cap of $106.60 billion, a P/E ratio of 16.91, a P/E/G ratio of 1.55 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. During the same quarter last year, the business posted $6.96 EPS. HCA Healthcare’s quarterly revenue was up 3.6% compared to the same quarter last year. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is presently 10.34%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Friday, October 2nd. BMO Capital Markets began coverage on shares of HCA Healthcare in a research note on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 target price on the stock. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. TD Cowen increased their price target on HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a report on Wednesday, October 28th. Finally, Bank of America raised their price objective on HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research report on Wednesday, October 28th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $480.13.

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.